News

Multi-Million Dollar Expansion to UK Manufacturing Facility

We are pleased to announce a significant expansion of our world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted oncology therapies.

PCI Pharma Services Selects Thoughtworks for Digital Platform Transformation with Agile Approach

Thoughtworks (NASDAQ: TWKS), a global technology consultancy that integrates strategy, design and engineering to drive digital innovation, today announced the signing of a multi-year agreement with PCI Pharma Services, a leading global contract development and manufacturing organization (CDMO). Thoughtworks will help us in our journey to digitize our supply chain, with the goal of accelerating […]

Humanigen Enters into Agreement with PCI Pharma Services as Part of Preparations for Commercialization in the United Kingdom

Humanigen, Inc. A late-stage clinical biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ has agreed with PCI Pharma Services to provide importation, release, and commercialization services in the UK for lenzilumab.

Expanding Our Bedford Campus, Adding 150 Jobs

PCI Pharma Services: A global pharmaceutical manufacturing company that develops, manufactures, and packages life-changing therapies for patients all around the world is expanding its campus in Bedford. Originally posted in Union Leader in May 2022 PCI Pharma Services acquired Bedford-based life sciences provider Lyophilization Services of New England (LSNE) in December 2021. Following that acquisition, […]

Major Manufacturing Expansion and $100 Million Investment at the Bedford, New Hampshire campus.

PCI Pharma Services is pleased to announce a major expansion of capabilities and capacity in aseptic liquid fill-finish and sterile lyophilization technology, an important manufacturing process commonly used with injectable and biologic therapies, with the investment of $100 million into the construction and enhancement of world-class facilities, at our Bedford, New Hampshire campus.

ESG Update: PCI Pharma Services Awarded Bronze Medal for Sustainability Performance!

Our corporate score of 54 is a 70% increase from our previous assessment result and effectively puts PCI among the top 32% of all companies assessed by EcoVadis. The improved rating is a result of the collective effort by the Global ESG Work Team as well as the larger PCI employee base who contributed to the process.

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.